We are live on
!
Find out more
Cambridge Investment Research Advisors Portfolio holdings
AUM
$44.6B
1-Year Est. Return
28.94%
This Fund
S&P 500
This Quarter
Est. Return
+6.8%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$20.4B
AUM Growth
+$1.11B
(+5.8%)
Cap. Flow
+$100M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
18.19%
Holding
3,316
New
217
Increased
1,367
Reduced
1,468
Closed
167
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$43.9M |
| 2 |
JPMorgan BetaBuilders US Aggregate Bond ETF
BBAG
|
+$31.7M |
| 3 |
iShares Core S&P US Value ETF
IUSV
|
+$27.7M |
| 4 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$26.5M |
| 5 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$22.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$44.6M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$30.3M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$30.3M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$30.2M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$28.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.45% |
| 2 | Financials | 4.68% |
| 3 | Healthcare | 4.07% |
| 4 | Consumer Discretionary | 3.92% |
| 5 | Industrials | 2.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Fidelity Limited Term Bond ETF
FLTB
$436M
| $201K | ﹤0.01% |
4,147
-33
| -0.8% | -$1.59K |
|
2827
Aptus Enhanced Yield ETF
JUCY
$328M
| $201K | ﹤0.01% |
+8,047
| New | +$202K |
|
2828
JELD-WEN Holding
JELD
$170M
| $200K | ﹤0.01% |
15,791
| – | – |
|
2829
Tetra Tech
TTEK
$9.03B
| $200K | ﹤0.01% |
6,815
-4,660
| -41% | -$135K |
|
|
HEAL
2830
Global X Funds Global X HealthTech ETF
HEAL
$31M
| $200K | ﹤0.01% |
5,677
-106
| -2% | -$3.81K |
|
2831
Manitowoc
MTW
$732M
| $199K | ﹤0.01% |
11,638
-2,486
| -18% | -$37.2K |
|
|
CIM
2832
Chimera Investment
CIM
$1B
| $198K | ﹤0.01% |
11,676
+421
| +4% | +$8.05K |
|
2833
Melco Resorts & Entertainment
MLCO
$2.15B
| $197K | ﹤0.01% |
+15,436
| New | +$199K |
|
|
INNO
2834
DELISTED
Harbor Disruptive Innovation ETF
INNO
| $197K | ﹤0.01% |
15,599
-619
| -4% | -$7.43K |
|
|
IMGN
2835
DELISTED
Immunogen Inc
IMGN
| $197K | ﹤0.01% |
51,401
+636
| +1% | +$2.71K |
|
2836
ING
ING
$102B
| $196K | ﹤0.01% |
16,544
-1,535
| -8% | -$20.3K |
|
|
LAZR
2837
DELISTED
Luminar Technologies
LAZR
| $196K | ﹤0.01% |
2,012
+20
| +1% | +$2.1K |
|
2838
First Majestic Silver
AG
$9.19B
| $195K | ﹤0.01% |
27,076
-57,235
| -68% | -$422K |
|
|
GLV
2839
Clough Global Dividend & Income Fund
GLV
$78.6M
| $195K | ﹤0.01% |
33,735
-3,173
| -9% | -$19.4K |
|
2840
Opko Health
OPK
$1.04B
| $193K | ﹤0.01% |
131,974
-3,065
| -2% | -$3.94K |
|
2841
Plains All American Pipeline
PAA
$16.4B
| $193K | ﹤0.01% |
15,508
+3,620
| +30% | +$45.2K |
|
2842
CleanSpark
CLSK
$3.09B
| $192K | ﹤0.01% |
69,051
-1,300
| -2% | -$3.57K |
|
2843
PIMCO RAFI Dynamic Multi-Factor Emerging Markets Equity ETF
MFEM
$151M
| $192K | ﹤0.01% |
10,585
-762
| -7% | -$13.8K |
|
2844
Viavi Solutions
VIAV
$10.7B
| $191K | ﹤0.01% |
17,659
+1,234
| +8% | +$13.4K |
|
2845
Nuveen Taxable Municipal Income Fund
NBB
$457M
| $190K | ﹤0.01% |
11,802
+332
| +3% | +$5.41K |
|
2846
Horizon Technology Finance
HRZN
$338M
| $188K | ﹤0.01% |
+16,649
| New | +$199K |
|
2847
Macy's
M
$6.19B
| $188K | ﹤0.01% |
10,726
-2,162
| -17% | -$45.7K |
|
2848
Gen Digital
GEN
$17.2B
| $186K | ﹤0.01% |
10,854
-8,841
| -45% | -$177K |
|
|
HEP
2849
DELISTED
Holly Energy Partners, L.P.
HEP
| $186K | ﹤0.01% |
+10,714
| New | +$197K |
|
2850
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$606M
| $185K | ﹤0.01% |
17,541
+4,500
| +35% | +$50K |
|
Similar funds
LP
TI
Cambridge Investment Research Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Cambridge Investment Research Advisors held 3,316 positions worth $20.4B, up 5.8% from $19.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cambridge Investment Research Advisors's Q1 2023 filing shows 217 new, 1,367 increased, 1,468 reduced and 167 closed positions. Its largest new stake was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M. The largest sale was iShares 0-1 Year Treasury Bond ETF, an estimated $44.6M.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8% a quarter earlier, followed by Financials and Healthcare.
- Cambridge Investment Research Advisors's largest Q1 2023 buy was State Street SPDR Bloomberg International Treasury Bond ETF: 735,671 shares worth $17M.
- Cambridge Investment Research Advisors added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2023, an estimated $43.9M increase.
- Cambridge Investment Research Advisors's biggest Q1 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $44.6M.
- Cambridge Investment Research Advisors fully exited ProShares Short Russell2000 in Q1 2023, selling an estimated $4.61M.
- Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $20.4B portfolio in Q1 2023.
- Cambridge Investment Research Advisors opened 217 new positions and closed 167 in Q1 2023.
- Cambridge Investment Research Advisors's portfolio value rose 5.8% quarter-over-quarter to $20.4B.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2023, filed 11 May 2023.